BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lonardo A, Adinolfi LE, Restivo L, Ballestri S, Romagnoli D, Baldelli E, Nascimbeni F, Loria P. Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen. World J Gastroenterol 2014; 20(23): 7089-7103 [PMID: 24966582 DOI: 10.3748/wjg.v20.i23.7089]
URL: https://www.wjgnet.com/1948-5182/full/v20/i23/7089.htm
Number Citing Articles
1
Hend I. Shousha, Rasha A. Abdelaziz, Sherief M. Azab, Marwa Khairy, Shahira A. Afifi, Mai I. Mehrez, Mohamed A. Eshra, Ayman Y. Abdelrahim. Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis CJournal of Medical Virology 2018; 90(6): 1099 doi: 10.1002/jmv.25062
2
Neda Nasheri, Zhibin Ning, Daniel Figeys, Shao Yao, Natalie K. Goto, John Paul Pezacki. Activity-based profiling of the proteasome pathway during hepatitis C virus infectionPROTEOMICS 2015; 15(22): 3815 doi: 10.1002/pmic.201500169
3
Katsumi Iizuka. Dietary Interventions in Liver Disease2019; : 263 doi: 10.1016/B978-0-12-814466-4.00022-7
4
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetesMetabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
5
Salvatore Petta. Hepatitis C virus and cardiovascular: A reviewJournal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
6
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded reviewWorld Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
7
Jennifer C. Price, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion G. Peters, Susan M. Noworolski, Phyllis C. Tien. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infectionHepatology 2017; 65(3): 853 doi: 10.1002/hep.28968
8
Thomas Pembroke, Marc Deschenes, Bertrand Lebouché, Amine Benmassaoud, Maida Sewitch, Peter Ghali, Philip Wong, Alex Halme, Elise Vuille-Lessard, Costa Pexos, Marina B. Klein, Giada Sebastiani. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosisJournal of Hepatology 2017; 67(4): 801 doi: 10.1016/j.jhep.2017.05.011
9
Luigi Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone, Mauro Giordano, Rosa Zampino. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsInternational Journal of Molecular Sciences 2016; 17(6): 803 doi: 10.3390/ijms17060803
10
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
11
Amedeo Lonardo, Alessandro Mantovani. Clearing hepatitis C virus with direct antiviral agents reduces cardiovascular events in patients with prediabetes. Commentary to Sasso and colleaguesNutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2354 doi: 10.1016/j.numecd.2021.05.019
12
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
13
Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin. Hepatitis C virus infection and diabetes: A complex bidirectional relationshipDiabetes Research and Clinical Practice 2022; 187: 109870 doi: 10.1016/j.diabres.2022.109870
14
G. Targher, A. Lonardo, M. Rossini. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?Journal of Endocrinological Investigation 2015; 38(8): 817 doi: 10.1007/s40618-015-0315-6
15
Yanping Chen, Dan Cao, Chunyan Li, Pingping Zhang, Xiaoyun Wang, Na Li, Qunying Han, Zhengwen Liu. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis BEuropean Journal of Gastroenterology & Hepatology 2021; 33(1): 69 doi: 10.1097/MEG.0000000000001691
16
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infectionWorld Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
17
Gehan S. Seifeldein, Elham A. Hassan, Hala M. Imam, Rania Makboul, Naglaa K. Idriss, Marwa A. Gaber, Reem M. Elkady. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosisEgyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00590-2
18
Amedeo Lonardo, Giovanni Targher. NAFLD: Is There Anything New under the Sun?International Journal of Molecular Sciences 2017; 18(9): 1955 doi: 10.3390/ijms18091955
19
Yoshihiro Ikura. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesWorld Journal of Hepatology 2014; 6(12): 894-900 doi: 10.4254/wjh.v6.i12.894
20
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological ResponseDiagnostics 2022; 12(3): 702 doi: 10.3390/diagnostics12030702
21
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
22
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseasesMetabolism 2017; 72: 57 doi: 10.1016/j.metabol.2017.04.003
23
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current statusMedicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
24
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, Ritsuzo Kozuka, Hideki Fujii, Sawako Uchida-Kobayashi, Shinya Fukunishi, Yasuhiro Tsuda, Kazuhide Higuchi, Masaki Saito, Hirayuki Enomoto, Norifumi Kawada. Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis BHepatology Research 2018; 48(6): 459 doi: 10.1111/hepr.13050
25
E. Shao. Reference Module in Biomedical Sciences2018;  doi: 10.1016/B978-0-12-801238-3.11046-3
26
Georg Semmler, Judith Stift, Bernhard Scheiner, Katharina Wöran, Philipp Schwabl, Rafael Paternostro, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Arnulf Ferlitsch, Michael Trauner, Thomas Reiberger, Mattias Mandorfer. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionDigestive Diseases and Sciences 2019; 64(12): 3642 doi: 10.1007/s10620-019-05702-7
27
Zita Galvin, Ramraj Rajakumar, Emily Chen, Oyedele Adeyi, Markus Selzner, David Grant, Gonzalo Sapisochin, Paul Greig, Mark Cattral, Ian McGilvray, Anand Ghanekar, Nazia Selzner, Les Lilly, Keyur Patel, Mamatha Bhat. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated FibrosisLiver Transplantation 2019; 25(1): 56 doi: 10.1002/lt.25338
28
Annalisa Cespiati, Salvatore Petta, Rosa Lombardi, Vito Di Marco, Vincenza Calvaruso, Cristina Bertelli, Giuseppina Pisano, Erika Fatta, Giordano Sigon, Federica Iuculano, Luciano Crapanzano, Gerlando Gibilaro, Paolo Francione, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)Digestive and Liver Disease 2021; 53(10): 1301 doi: 10.1016/j.dld.2020.11.001
29
Mauro Piacentini, Andrea Baiocchini, Franca Del Nonno, Gerry Melino, Nickolai A. Barlev, Federica Rossin, Manuela D’Eletto, Laura Falasca. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2Cell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0292-8
30
Nathan J Shores, Maria Cássia Mendes-Corrêa, Ivana Maida, JoLyn Turner, Kevin P High, Sergio Babudieri, Marina Núñez. Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicityClinics 2015; 70(12): 790 doi: 10.6061/clinics/2015(12)05
31
C Hamoir, Y Horsmans, P Stärkel, G Dahlqvist, S Negrin Dastis, N Lanthier. Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agentsActa Gastro Enterologica Belgica 2021; 84(1): 25 doi: 10.51821/84.1.420
32
Kamila Wójcik, Anna Piekarska, Alina Dąbrowicz, Marta Stasiak, Katarzyna Gawryś, Elżbieta Jabłonowska. Hepatic Expression of Phosphorylated Kinase Akt and Glycogen Synthase Kinase-3 Isoforms in Patients with Chronic Hepatitis CViral Immunology 2019; 32(4): 179 doi: 10.1089/vim.2018.0141
33
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic ReviewDigestive Diseases and Sciences 2015; 60(9): 2813 doi: 10.1007/s10620-015-3760-3
34
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVWorld Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
35
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
36
Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J.Mark Brown. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosisJournal of Lipid Research 2017; 58(2): 420 doi: 10.1194/jlr.M073734
37
Anand Rattansingh, Hosein Amooshahi, Ravi J Menezes, Florence Wong, Sandra Fischer, Richard Kirsch, Mostafa Atri. Utility of shear-wave elastography to differentiate low from advanced degrees of liver fibrosis in patients with hepatitis C virus infection of native and transplant liversJournal of Clinical Ultrasound 2018; 46(5): 311 doi: 10.1002/jcu.22583
38
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patientsDigestive and Liver Disease 2019; 51(1): 142 doi: 10.1016/j.dld.2018.07.003
39
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Amedeo Lonardo. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in HumansAdvances in Therapy 2016; 33(3): 291 doi: 10.1007/s12325-016-0306-9
40
Giuseppe Indolfi, Maria Guido, Chiara Azzari, Massimo Resti. Histopathology of hepatitis C in children, a systematic review: implications for treatmentExpert Review of Anti-infective Therapy 2015; 13(10): 1225 doi: 10.1586/14787210.2015.1070668
41
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancerBiological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
42
Non-Neoplastic Diseases of the Liver2022; : 265 doi: 10.55418/9781933477183-9
43
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way AssociationFrontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
44
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
45
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the SpotlightInternational Journal of Molecular Sciences 2016; 17(3): 355 doi: 10.3390/ijms17030355
46
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
47
J. Shah, E. Shao. Encyclopedia of Cardiovascular Research and Medicine2018; : 514 doi: 10.1016/B978-0-12-809657-4.11046-4
48
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actualMedicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
49
Thomas Karlas, Johanna Kollmeier, Stephan Böhm, Jürgen Müller, Peter Kovacs, Michael Tröltzsch, Antje Weimann, Michael Bartels, Jonas Rosendahl, Joachim Mössner, Thomas Berg, Volker Keim, Johannes Wiegand. Noninvasive characterization of graft steatosis after liver transplantationScandinavian Journal of Gastroenterology 2015; 50(2): 224 doi: 10.3109/00365521.2014.983156
50
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
51
Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Digestive and Liver Disease 2016; 48(2): 105 doi: 10.1016/j.dld.2015.10.016
52
M. I. Valetskyi, M. U. Zak, O. V. Chernyshov, M. V. Sverdlova, V. S. Potochniak. Chronic Viral Hepatitis C: The Evolution of Scientific ViewsUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(5): 9 doi: 10.26693/jmbs05.05.009
53
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factorsWorld Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
54
Hisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, Satoshi Miuma, Takuya Honda, Hidetaka Shibata, Kan Toriyama, Kazuhiko Nakao. Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver DiseaseInternal Medicine 2016; 55(9): 1049 doi: 10.2169/internalmedicine.55.5288
55
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral TherapyHepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
56
Caterina Sagnelli, Marco Merli, Caterina Uberti-Foppa, Hamid Hasson, Anna Grandone, Grazia Cirillo, Stefania Salpietro, Carmine Minichini, Mario Starace, Emanuela Messina, Patrizia Morelli, Emanuele Miraglia Del Giudice, Adriano Lazzarin, Nicola Coppola, Evangelista Sagnelli. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotypeWorld Journal of Gastroenterology 2016; 22(38): 8509-8518 doi: 10.3748/wjg.v22.i38.8509
57
Kyoko Tsukiyama-Kohara, Michinori Kohara. Hepatitis C Virus: Viral Quasispecies and GenotypesInternational Journal of Molecular Sciences 2017; 19(1): 23 doi: 10.3390/ijms19010023
58
Mona K. ElDeeb, Abeer A. Ghazal, Dalia E. Metwally, Lamya A. Elghlied. Possible roles of methylenetetrahydrofolate reductase polymorphism and folate status in patients with early hepatitis C virus genotype 4Arab Journal of Gastroenterology 2021; 22(2): 121 doi: 10.1016/j.ajg.2020.12.001
59
Tatsuo Kanda, Mitsuhiko Moriyama. Direct-acting antiviral agents against hepatitis C virus and lipid metabolismWorld Journal of Gastroenterology 2017; 23(31): 5645-5649 doi: 10.3748/wjg.v23.i31.5645
60
I. Valkov, R. Ivanova, C. Marinova, A. Alexiev, K. Antonov, D. Jelev, R. S. Ivanova, L. Mateva. A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy ControlsActa Medica Bulgarica 2017; 44(1): 5 doi: 10.1515/amb-2017-0001
61
Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, Andreas Geier, Pavel Strnad. Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-RegistryPLOS ONE 2022; 17(6): e0264741 doi: 10.1371/journal.pone.0264741
62
Valerie A. Villareal, Dan Fu, Deirdre A. Costello, Xiaoliang Sunney Xie, Priscilla L. Yang. Hepatitis C Virus Selectively Alters the Intracellular Localization of DesmosterolACS Chemical Biology 2016; 11(7): 1827 doi: 10.1021/acschembio.6b00324
63
Steven Roger, Alexandra Ducancelle, Hélène Le Guillou-Guillemette, Catherine Gaudy, Françoise Lunel. HCV virology and diagnosisClinics and Research in Hepatology and Gastroenterology 2021; 45(3): 101626 doi: 10.1016/j.clinre.2021.101626
64
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
65
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral TreatmentsBiomedicines 2021; 9(10): 1491 doi: 10.3390/biomedicines9101491
66
Jamak Modaresi Esfeh, Kianoush Ansari-Gilani. Steatosis and hepatitis CGastroenterology Report 2015; : gov040 doi: 10.1093/gastro/gov040
67
Cordelia Manickam, Lynn Wachtman, Amanda J. Martinot, Luis D. Giavedoni, R. Keith Reeves, Gualtiero Alvisi. Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus)PLOS ONE 2017; 12(1): e0170240 doi: 10.1371/journal.pone.0170240
68
D. Crisan, C. Radu, A. Suciu, N. Leach, H. Stefanescu, L. Avram, N. Crisan, M. Grigorescu. Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a differenceJournal of Viral Hepatitis 2017; 24(1): 86 doi: 10.1111/jvh.12610